Photocure ASA: Results for the second quarter of 2026
Source: PRNewswire· July 29, 2026
OSLO, Norway, July 29, 2026 /PRNewswire/ -- Photocure ASA (OSE: PHO) today reported Hexvix®/Cysview® revenues of NOK 140.0 million in the second quarter of 2026 (Q2 2025: NOK 135.6 million), and an adjusted EBITDA of NOK 27.2 million (Q2 2025: NOK 27.0 millio…
This story was reported by PRNewswire. Read the full original article:
Read on PRNewswire 